The Cell and Gene Therapy Catapult (CGT Catapult) and Deep Science Ventures, a London-based venture creator, have collaboratively launched a partnership to generate innovative approaches that address barriers in the advanced therapy medicinal products (ATMP) industry. The partnership’s goals are to create new companies and deliver better patient outcomes, CGT Catapult announced. Source: Biopharm International 19/11/2021